ArticleNature communications2024
Long-term relapse-free survival enabled by integrating targeted antibacteria in antitumor treatment.
Yuanlin Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it